Home » Headlines » Currently Reading:

Morning Headlines 12/11/24

December 10, 2024 Headlines No Comments

Oracle Announces Fiscal 2025 Second Quarter Financial Results

Oracle reports Q2 results: revenue up 9%, EPS $1.10 versus $0.89, missing Wall Street expectations for both and sending shares moderately down.

Healthier Capital Invests in Hyro’s Responsible AI Agents for Healthcare

Healthcare conversational AI company Hyro extends its Series B round of funding, bringing its total raised to $50 million.

Walgreens shares soar 20% on reported talks to sell itself to Sycamore Partners

Walgreens is reportedly considering selling itself to private equity firm Sycamore Partners in a take-private transaction.

Evidently Closes $15M Series A

Healthcare workflow AI startup Evidently raises $15 million in a Series A funding round.



HIStalk Featured Sponsors

     

Founding Sponsors


 

Platinum Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gold Sponsors


 

 

 

 

 

 

 

 

Text Ads


HIStalk Text Ads
Big audience, low price.
Seven lines on the
most talked about site
in the industry. Easy -
your ad starts in hours
and is seen by thousands
of visitors each day.

more ...

Advertise here
Do you trust government-led health data initiatives to handle your personal health information securely and responsibly?

RECENT COMMENTS

  1. Regarding Medstar - I have to wonder how many decisions were made to go to Cerner over Epic based on…

  2. It took a while to plough through 4 hours of Acquired podcast. I have been a fan of their work…

  3. (Cough, the same kind of dingbat who doesn't think autistic people play BASEBALL. Of all the examples to choose...)

  4. Re: "Kennedy has stated that HHS will determine the cause of autism by September.” I mean, what kind of a…

  5. 100% - i do think Mr H has shed pretty good light on the Wage Prevention Act building up this…

RSS Webinars

  • An error has occurred, which probably means the feed is down. Try again later.